Ellington Financial Reveals Estimated Book Value for November 2024
December 31, 2024 - 00:43
OLD GREENWICH, Conn., December 30, 2024—Ellington Financial Inc. has disclosed its estimated book value per share of common stock, reporting a figure of $13.47 as of November 30, 2024. This announcement comes in the wake of the company's previously communicated monthly dividend of $0.13 per share, which was distributed to shareholders on December 26, 2024.
The dividend payment was made to those on record as of November 29, 2024, aligning with the same ex-dividend date. The estimated book value reflects the company's ongoing commitment to providing value to its shareholders while navigating the complexities of the financial landscape.
Investors and market analysts will likely scrutinize this estimate as it provides insight into the company's financial health and performance. As the year draws to a close, Ellington Financial continues to focus on strategic initiatives aimed at enhancing shareholder value and maintaining a robust financial position in the competitive market.
MORE NEWS
September 12, 2026 - 00:50
US Tariff Refunds Slow as Government Collects More Than It Pays OutThe flow of tariff refunds from the US government has slowed sharply, with new figures showing the Treasury took in more money from tariffs than it returned to importers for the first time in...
September 11, 2026 - 02:46
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another StoryRayonier Advanced Materials reported second-quarter results on August 4 for the period ending June 27, showing a mixed picture of financial performance. Net sales reached $376 million, an 18...
September 10, 2026 - 21:54
OpenAI Rolls Out ChatGPT for Financial Services With Major Industry PartnersOpenAI has introduced a version of ChatGPT built specifically for the financial sector, teaming up with several large brokerages and research organizations, including Morgan Stanley and S&P. The...
September 10, 2026 - 04:58
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateVancouver-based InMed Pharmaceuticals has released its financial results for the full fiscal year that ended on June 30, 2026, alongside a broader update on its corporate activities. The company,...